| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Chartis, a leading healthcare advisory firm, today announced that it has entered into a definitive agreement to receive a majority investment from funds managed by Blackstone ("Blackstone"). This strategic investment will support the firm's continued growth as a leading advisor to providers, payers, technology innovators, retail companies, and investors who are making positive and transformative change within US healthcare. The investment includes continued equity participation from Audax Private Equity ("Audax").
Blackstone is investing in Chartis through its core private equity strategy, which partners with high-quality, market-leading businesses for longer periods than traditional private equity. The investment will enable Chartis to further extend its capabilities across its strategic, digital and technology, clinical, and financial transformation offerings for healthcare clients. This funding is also anticipated to help further expand the full Chartis family of companies, currently including HealthScape Advisors, Jarrard, and Greeley.
Posted In: BX
